Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Evaluation of the European LeukemiaNet recommendations for predicting outcomes of patients with acute myeloid leukemia treated in low- and middle-income countries (LMIC): A Brazilian experience.

Benicio MTL, Ribeiro AFT, Américo AD, Furtado FM, Glória AB, Lima AS, Santos SM, Xavier SG, Lucena-Araujo AR, Fagundes EM, Rego EM.

Leuk Res. 2017 Sep;60:109-114. doi: 10.1016/j.leukres.2017.07.005. Epub 2017 Jul 24.

PMID:
28777950
2.

Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia.

Bezerra MF, Coelho-Silva JL, Nascimento JC, Benicio MT, Rocha CR, Machado CG, Rego EM, Bezerra MA, Lucena-Araujo AR, Beltrão EI.

Haematologica. 2017 Feb;102(2):e43-e46. doi: 10.3324/haematol.2016.155069. Epub 2016 Oct 20. No abstract available.

3.

Genetic mutations in patients with acute myeloid leukemia and leukostasis.

De Santis GC, Benicio MT, Oliveira LC, Falcão RP, Rego EM.

Acta Haematol. 2013;130(2):95-7. doi: 10.1159/000346442. Epub 2013 Mar 23. No abstract available.

PMID:
23548579
4.

Methionine-induced hyperhomocysteinemia reverts fibrinolytic pathway activation in a murine model of acute promyelocytic leukemia.

Jácomo RH, Santana-Lemos BA, Lima AS, Assis PA, Lange AP, Figueiredo-Pontes LL, Oliveira LO, Bassi SC, Benício MT, Baggio MS, Garcia AB, Falcão RP, Rego EM.

Blood. 2012 Jul 5;120(1):207-13. doi: 10.1182/blood-2011-04-347187. Epub 2012 Apr 19.

5.

Results of FLT3 mutation screening and correlations with immunophenotyping in 169 Brazilian patients with acute myeloid leukemia.

Lucena-Araujo AR, Souza DL, Morato de Oliveira F, Benicio MT, Figueiredo-Pontes LL, Santana-Lemos BA, dos Santos GA, Jacomo RH, Dinarte-Santos AR, Yamamoto M, Silva WA Jr, de Lourdes Chauffaille M, Rego EM.

Ann Hematol. 2010 Feb;89(2):225-8. doi: 10.1007/s00277-009-0860-1. No abstract available. Erratum in: Ann Hematol. 2010 Feb;89(2):229-30.

PMID:
19921191

Supplemental Content

Loading ...
Support Center